Short Interest in Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Expands By 127.4%

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) saw a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 48,900 shares, an increase of 127.4% from the February 13th total of 21,500 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

Laboratorios Farmaceuticos Rovi Stock Performance

Laboratorios Farmaceuticos Rovi stock opened at C$65.86 on Friday. The firm has a 50-day moving average of C$65.86 and a 200-day moving average of C$76.94. Laboratorios Farmaceuticos Rovi has a 1-year low of C$65.86 and a 1-year high of C$65.86.

About Laboratorios Farmaceuticos Rovi

Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.